Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Formula Systems (1985) (FORTY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Formula Systems (1985) (FORTY) over the last 17 years, with Q3 2025 value amounting to $431.3 million.

  • Formula Systems (1985)'s Cash & Equivalents fell 817.5% to $431.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $431.3 million, marking a year-over-year decrease of 817.5%. This contributed to the annual value of $507.8 million for FY2024, which is 1235.83% up from last year.
  • Per Formula Systems (1985)'s latest filing, its Cash & Equivalents stood at $431.3 million for Q3 2025, which was down 817.5% from $393.2 million recorded in Q2 2025.
  • In the past 5 years, Formula Systems (1985)'s Cash & Equivalents registered a high of $544.3 million during Q4 2022, and its lowest value of $386.0 million during Q2 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $447.9 million (2023), whereas its average is $450.5 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 2444.68% in 2022, then tumbled by 1697.39% in 2023.
  • Over the past 5 years, Formula Systems (1985)'s Cash & Equivalents (Quarter) stood at $485.4 million in 2021, then increased by 12.14% to $544.3 million in 2022, then fell by 16.97% to $451.9 million in 2023, then increased by 12.36% to $507.8 million in 2024, then decreased by 15.06% to $431.3 million in 2025.
  • Its Cash & Equivalents stands at $431.3 million for Q3 2025, versus $393.2 million for Q2 2025 and $461.8 million for Q1 2025.